Treatment Preference and Patient Centered Prostate Cancer Care
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | June 2013 |
| End Date: | June 2016 |
The purpose of this study is to develop a preference based decision aid to assess the
treatment preferences of prostate cancer patients, and to analyze the interaction of
treatment preferences, type of treatment received and their relationship with health related
quality of life, satisfaction with care, decision regret, and psychological health of men
with localized prostate cancer.
treatment preferences of prostate cancer patients, and to analyze the interaction of
treatment preferences, type of treatment received and their relationship with health related
quality of life, satisfaction with care, decision regret, and psychological health of men
with localized prostate cancer.
The objective is to test the comparative effectiveness of a conjoint analysis decision aid
intervention compared to usual care. The investigators will identify preferred attributes of
prostate cancer treatments that will help in designing a conjoint analysis decision aid to
help patients weigh treatment attributes. The investigators will employ values markers to
represent clusters of values for particular aspects of treatments that are valued most by
individual patients. The investigators will test if the concordance between values markers
and treatment received is predictive of objective outcomes and subjective outcomes. The
study hypothesis is that conjoint task may help in treatment choice and prostate cancer
patients whose treatment is more concordant with their values markers will have improved
outcomes.
intervention compared to usual care. The investigators will identify preferred attributes of
prostate cancer treatments that will help in designing a conjoint analysis decision aid to
help patients weigh treatment attributes. The investigators will employ values markers to
represent clusters of values for particular aspects of treatments that are valued most by
individual patients. The investigators will test if the concordance between values markers
and treatment received is predictive of objective outcomes and subjective outcomes. The
study hypothesis is that conjoint task may help in treatment choice and prostate cancer
patients whose treatment is more concordant with their values markers will have improved
outcomes.
Inclusion Criteria:
1. Newly diagnosed with non-metastatic prostate cancer
2. Has not yet started radiation or surgery
3. Provide informed consent
Exclusion Criteria:
1. Distant, metastatic prostate cancer at diagnosis
2. Has already begun treatment for prostate cancer
3. Unable to communicate in English
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials